Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT00894829

Completed

Efficacy and Safety of Sodium Heparin (Eurofarma)

Cardiac Surgery
NCT01020747

Completed

Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)

Recurrent Respiratory Papillomatosis
NCT01123564

Unknown

Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion (BRAVO)

Macular Edema | Retinal Vein Occlusion
NCT00994799

Unknown

Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema

Macular Edema
NCT00306813

Completed

Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma

Refractory Multiple Myeloma | Relapse
NCT00848796

Completed

Comparative Study of Two Brands of Heparin Already on the Market

Coronary Artery Bypass Grafting
NCT00039767

Completed

Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices

Thrombosis
NCT00383136

Completed

FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab (FATA)

Acute Myocardial Infarction
NCT06282445

Recruiting

Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

Colorectal Cancer Metastatic
NCT05942053

Recruiting

Role of Vitamin K2 in Chronic Kidney Disease

Chronic Kidney Diseases
NCT05799820

Recruiting

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

Colorectal Carcinoma
NCT05751343

Recruiting

Atezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical Trial

Hepatocellular Carcinoma
NCT07241494

Completed

Evaluation of Clinical Pharmacy Services and Drug Use in Renal Impairment. (RECAP-Rx)

Chronic Kidney Disease | Acute Kidney Disease | Medication Errors | Renal Impairments
NCT04669782

Terminated

Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging (OstMARK)

Osteoporosis | Aging Disorder | Bone Metabolism Disorder
NCT06223958

Active, not recruiting

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

Neovascular Age-Related Macular Degeneration
NCT06503250

Completed

A Study of Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab and Bevacizumab Plus Transarterial Chemoembolization

Unresectable Hepatocellular Carcinoma
NCT04409223

Terminated

Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib

Gastrointestinal Stromal Tumors
NCT05675163

Completed

Antioxidant and Immune Effects of Vitamin K2 (ProteK2t)

Inflammation | Oxidative Stress
NCT02354131

Completed

Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer (AVANOVA)

Ovarian Cancer
NCT00264277

Completed

D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism

Deep Vein Thrombosis | Pulmonary Embolism
NCT00668811

Completed

Sutent Adjunctive Treatment of Differentiated Thyroid Cancer (IIT Sutent)

Papillary Thyroid Cancer | Differentiated Thyroid Cancer | Follicular Thyroid Cancer
NCT00095459

Completed

BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors

Neoplasms
NCT00891878

Completed

Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction

Esophageal Cancer | Adenocarcinoma of the Gastroesophageal Junction
NCT00621686

Completed

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Brain and Central Nervous System Tumors
NCT02512601

Terminated

Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide (SQUARES)

Post-thrombotic Syndrome
NCT00847119

Completed

Xeloda and Bevacizumab to Treat Rectal Cancer (xeberecto)

Rectal Cancer
NCT00887822

Completed

A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer (AVATAR)

Gastric Cancer
NCT01332604

Completed

GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors

Solid Cancers
NCT00556205

Withdrawn

Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma

Renal Cell Carcinoma
NCT00367601

Completed

Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer

Lung Cancer
NCT00982657

Terminated

A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma

Solid Tumor
NCT00442507

Terminated

Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction (OSI3650)

Esophageal Neoplasms | Esophageal Diseases
NCT00389974

Completed

Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery

Cervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Cancer | Stage IVB Cervical Cancer | Cervical Adenosquamous Cell Carcinoma
NCT00388037

Completed

Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Stage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIC Fallopian Tube Cancer | Stage IV Fallopian Tube Cancer | Stage IIIA Ovarian Epithelial Cancer
NCT00495625

Terminated

Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)

Liver Cancer
NCT00842686

Unknown

Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study (CRAB)

Locally Advanced Rectal Cancer
NCT01235325

Completed

The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease Patients

Supplementation | Crohn's Disease | Bone Health
NCT00491738

Terminated

A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R)

Renal Cell Carcinoma
NCT00006155

Completed

SU5416 and Carboplatin to Treat Ovarian Cancer

Ovarian Cancer | Peritoneal Neoplasm | Fallopian Tube Neoplasm
NCT06584071

Not yet recruiting

A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC

HCC | Liver Cancer
NCT06377267

Recruiting

Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial) (STROBE)

Ovarian Cancer
NCT06364826

Not yet recruiting

Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
NCT03836066

Completed

Atezolizumab Plus Bevacizumab in First Line NSCLC Patients (TELMA)

Non Small Cell Lung Cancer
NCT00843037

Completed

Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma (SNIPP)

Pheochromocytoma | Paraganglioma
NCT03661723

Active, not recruiting

Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma

Glioblastoma
NCT04446793

No longer available

Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer

Metastatic Colorectal Cancer | KRAS Gene Mutation
NCT01869881

Completed

Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study)

Diabetic Nephropathy
NCT01429350

Completed

Assess the Penumbra System in the Treatment of Acute Stroke (THERAPY)

Ischemic Stroke
NCT00478426

Completed

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Uterine Carcinosarcoma | Recurrent Uterine Corpus Carcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Stage IVA Uterine Corpus Cancer AJCC v7 | Stage IVB Uterine Corpus Cancer AJCC v7 | Uterine Corpus Carcinosarcoma
NCT02335359

Completed

Tranexamic Acid in Major Vascular Surgery

Blood Loss, Surgical

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations